Australien - engelska - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - fentanyl citrate, quantity: 785 microgram (equivalent: fentanyl, qty 500 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - analgesic action of short duration during anaesthetic periods, premedication, induction and maintenance, and in the immediate post-operative period (recovery room) as the need arises - use as an opioid analgesic supplement in general and regional anaesthesia - administration with a neuroleptic such as droperidol injection as an anaesthetic premedication, for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - fentanyl citrate, quantity: 392.5 microgram (equivalent: fentanyl, qty 250 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - analgesic action of short duration during anaesthetic periods, premedication, induction and maintenance, and in the immediate post-operative period (recovery room) as the need arises - use as an opioid analgesic supplement in general and regional anaesthesia - administration with a neuroleptic such as droperidol injection as an anaesthetic premedication, for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - fentanyl citrate, quantity: 157 microgram (equivalent: fentanyl, qty 100 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections - analgesic action of short duration during anaesthetic periods, premedication, induction and maintenance, and in the immediate post-operative period (recovery room) as the need arises - use as an opioid analgesic supplement in general and regional anaesthesia - administration with a neuroleptic such as droperidol injection as an anaesthetic premedication, for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.

Israel - engelska - Ministry of Health

rafa laboratories ltd - fentanyl as citrate - solution for injection - fentanyl as citrate 0.05 mg/ml - fentanyl - fentanyl - for analgesic action of short duration during anesthtic periods (premedication induction and maintenance) and in the immediate postoperative period as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 314 microgram (equivalent: fentanyl, qty 200 microgram) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; sodium bicarbonate; mannitol; citric acid; sodium starch glycollate type a; sodium carbonate - fentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 1.257 mg (equivalent: fentanyl, qty 800 microgram) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; citric acid; sodium carbonate; sodium bicarbonate; sodium starch glycollate type a; mannitol - fentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 157 microgram (equivalent: fentanyl, qty 100 microgram) - tablet, orally disintegrating - excipient ingredients: mannitol; sodium carbonate; sodium bicarbonate; citric acid; sodium starch glycollate type a; magnesium stearate - fentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 943 microgram (equivalent: fentanyl, qty 600 microgram) - tablet, orally disintegrating - excipient ingredients: sodium bicarbonate; magnesium stearate; sodium carbonate; sodium starch glycollate type a; citric acid; mannitol - fentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - fentanyl citrate, quantity: 628 microgram (equivalent: fentanyl, qty 400 microgram) - tablet, orally disintegrating - excipient ingredients: magnesium stearate; sodium carbonate; sodium starch glycollate type a; sodium bicarbonate; citric acid; mannitol - fentora is indicated for the treatment of breakthrough pain (btp) in adults with cancer who are already receiving maintenance opioid therapy for chronic cancer pain.

Israel - engelska - Ministry of Health

a.l. medi-market ltd. - fentanyl as citrate - solution for injection - fentanyl as citrate 0.05 mg / 1 ml - fentanyl - for analgesic action of short duration during anesthtic periods (premedication induction and maintenance) and in the immediate postoperative period as need arises. as a narcotic analgesic supplement in general or regional anesthesia. for administration with neuroleptics (such as droperidol) as an anesthetic premedication for the induction of anesthesia and as an adjunct in the maintenance of general or regional anesthesia. for use as an anesthetic agent with oxygen in selected high-risk patients (open heart surgery or certain neurological or orthopedic procedures). by the epidural route for the postoperative management of pain following general surgical procedures and cesarean sections and as adjunct to general anesthesia.